Research Article

Low level laser therapy in rheumatoid arthritis: ultrasonographic and clinical assessment of efficacy

Volume: 6 Number: 2 June 30, 2021
EN

Low level laser therapy in rheumatoid arthritis: ultrasonographic and clinical assessment of efficacy

Abstract

Background: There are some conflicting reports in the literature about the effects of Low Level Laser therapy (LLLT) on Rheumatoid Arthritis (RA). The aim of the current study was to investigate the efficacy of LLLT treatment on synovial inflammation in the hand joints of patients with RA, via clinical and ultrasonography evaluations. Materials and Methods: We recruited 35 patients with RA and whose proximal interphalangeal joints had mild or moderate active synovitis. We divided subjects into two groups randomly; 18 participants were determined as the laser treatment group, while 17 patients were determined as placebo group. Laser therapy was applied at a dose of 0.6 J/cm2 to the joints. Clinical and ultrasonographical assessments were performed. Results: Both groups had reduction in morning joint stiffness at the end of the treatment and at 3 months after therapy; however, laser therapy caused a significantly higher reduction in morning joint stiffness compared to placebo. While placebo did not reduce DHİ scores at the end of the treatment LLLT reduced DHİ scores. Conclusion: Our results raise the possibility that low-level laser treatment of joints affected with RA may be effective, at least in part; however, further studies are needed in order to clarify the efficacy of LLLT on synovitis caused by RA.

Keywords

References

  1. 1. Inanir A, Yigit S, Karakus N, Tekin S, Rustemoglu A. Association of MEFV gene mutations with rheumatoid factor levels in patients with rheumatoid arthritis. J Investig Med. 2013;61(3):593-596.
  2. 2. Urbina-Joiro H, Cardiel MH, Alcocer-Varela J. Reclassifying the pathogenesis of rheumatoid arthritis: from the susceptibility to the degenerative stages. Clin Exp Rheumatol. 1998;16(1):87-91.
  3. 3. Weyand CM. New insights into the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford). 2000;39 Suppl 1(3-8.
  4. 4. Goronzy JJ, Zettl A, Weyand CM. T cell receptor repertoire in rheumatoid arthritis. Int Rev Immunol. 1998;17(5-6):339-363.
  5. 5. Etnel JRG, Helbing WA, Roos-Hesselink JW, The R, Bogers A, Takkenberg JJM. Patient and physician view on patient information and decision-making in congenital aortic and pulmonary valve surgery. Open Heart. 2018;5(2):e000872.
  6. 6. Li LC, Coyte PC, Lineker SC, Wood H, Renahan M. Ambulatory care or home-based treatment? An economic evaluation of two physiotherapy delivery options for people with rheumatoid arthritis. Arthritis Care Res. 2000;13(4):183-190.
  7. 7. Jette AM, Delitto A. Physical therapy treatment choices for musculoskeletal impairments. Phys Ther. 1997;77(2):145-154.
  8. 8. Arslan H, Doganay E, Karatas E, Unlu MA, Ahmed HMA. Effect of Low-level Laser Therapy on Postoperative Pain after Root Canal Retreatment: A Preliminary Placebo-controlled, Triple-blind, Randomized Clinical Trial. J Endod. 2017;43(11):1765-1769.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Authors

Nevbahar Akcar Degirmenci This is me
Türkiye

Cengiz Oner This is me
Türkiye

Publication Date

June 30, 2021

Submission Date

April 19, 2021

Acceptance Date

July 7, 2021

Published in Issue

Year 2021 Volume: 6 Number: 2

APA
Dinç Yavaş, A., Akcar Degirmenci, N., Berkan, F., & Oner, C. (2021). Low level laser therapy in rheumatoid arthritis: ultrasonographic and clinical assessment of efficacy. Journal of Immunology and Clinical Microbiology, 6(2), 69-80. https://izlik.org/JA52MP74AZ
AMA
1.Dinç Yavaş A, Akcar Degirmenci N, Berkan F, Oner C. Low level laser therapy in rheumatoid arthritis: ultrasonographic and clinical assessment of efficacy. J Immunol Clin Microbiol. 2021;6(2):69-80. https://izlik.org/JA52MP74AZ
Chicago
Dinç Yavaş, Arzu, Nevbahar Akcar Degirmenci, Funda Berkan, and Cengiz Oner. 2021. “Low Level Laser Therapy in Rheumatoid Arthritis: Ultrasonographic and Clinical Assessment of Efficacy”. Journal of Immunology and Clinical Microbiology 6 (2): 69-80. https://izlik.org/JA52MP74AZ.
EndNote
Dinç Yavaş A, Akcar Degirmenci N, Berkan F, Oner C (June 1, 2021) Low level laser therapy in rheumatoid arthritis: ultrasonographic and clinical assessment of efficacy. Journal of Immunology and Clinical Microbiology 6 2 69–80.
IEEE
[1]A. Dinç Yavaş, N. Akcar Degirmenci, F. Berkan, and C. Oner, “Low level laser therapy in rheumatoid arthritis: ultrasonographic and clinical assessment of efficacy”, J Immunol Clin Microbiol, vol. 6, no. 2, pp. 69–80, June 2021, [Online]. Available: https://izlik.org/JA52MP74AZ
ISNAD
Dinç Yavaş, Arzu - Akcar Degirmenci, Nevbahar - Berkan, Funda - Oner, Cengiz. “Low Level Laser Therapy in Rheumatoid Arthritis: Ultrasonographic and Clinical Assessment of Efficacy”. Journal of Immunology and Clinical Microbiology 6/2 (June 1, 2021): 69-80. https://izlik.org/JA52MP74AZ.
JAMA
1.Dinç Yavaş A, Akcar Degirmenci N, Berkan F, Oner C. Low level laser therapy in rheumatoid arthritis: ultrasonographic and clinical assessment of efficacy. J Immunol Clin Microbiol. 2021;6:69–80.
MLA
Dinç Yavaş, Arzu, et al. “Low Level Laser Therapy in Rheumatoid Arthritis: Ultrasonographic and Clinical Assessment of Efficacy”. Journal of Immunology and Clinical Microbiology, vol. 6, no. 2, June 2021, pp. 69-80, https://izlik.org/JA52MP74AZ.
Vancouver
1.Arzu Dinç Yavaş, Nevbahar Akcar Degirmenci, Funda Berkan, Cengiz Oner. Low level laser therapy in rheumatoid arthritis: ultrasonographic and clinical assessment of efficacy. J Immunol Clin Microbiol [Internet]. 2021 Jun. 1;6(2):69-80. Available from: https://izlik.org/JA52MP74AZ

88x31.png 

Creative Commons Attribution Non-Commercial License: The articles in the Journal of Immunology and Clinical Microbiology are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

JICM is a product of QMEL® medicine & publishing